HTA78 Comparative Analysis of Reimbursement Landscapes: Advantages and Challenges of Bispecifics vs. CAR-T Therapies
Abstract
Authors
Mark Chalmers PRATEEK KANADE Vidhyasagari Sundaram Mansi Deshpande
Mark Chalmers PRATEEK KANADE Vidhyasagari Sundaram Mansi Deshpande
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now